Members in the News: Patricia Brubaker Joins Royal Society of Canada

Endocrine Society member Patricia Brubaker, PhD, of the University of Toronto, has been recognized by the Royal Society of Canada for her accomplishments in the lab. She will join the prestigious Society as a fellow, as the University of Toronto points out.

Brubaker and her colleague, Endocrine Society member Daniel Drucker, MD, of Mount Sinai Hospital in Toronto, discovered that GLP-2 is an intestinal growth factor, which could be used to treat digestive disorders like Crohn’s and colitis.

Read the full story here. 

You may also like

  • Endocrine Society Urges Congress to Increase Funding for NIH

    Funding needed by start of new fiscal year to advance public health during pandemic The Endocrine Society is calling on Congress to pass the House Labor-HHS spending bill to ensure health agencies are funded before the start of Fiscal Year 2021 and to avoid the tumult and disruption of a continuing resolution and potential government shutdowns. The…

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…